Targeted therapies for cardiac diseases

被引：4
|
作者：
Maack, Christoph [1 ,2 ]
Tardiff, Jil C. [3 ]
机构：
[1] Univ Clin Wurzburg, Comprehens Heart Failure Ctr, Dept Translat Res, Wurzburg, Germany
[2] Univ Clin Wurzburg, Med Clin 1, Wurzburg, Germany
[3] Univ Arizona, Dept Biomed Engn & Med, Tucson, AZ USA
来源：
NATURE REVIEWS CARDIOLOGY | 2022年 / 19卷 / 06期
关键词：
HEART-FAILURE;
D O I：
10.1038/s41569-022-00704-x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Heart failure is a systemic disease in which neuroendocrine activation, inflammation and metabolic changes can impair cardiac function. In addition, variants in genes encoding sarcomeric proteins can predispose individuals to develop heart failure. The 2022 Gordon Research Conference on Cardiac Regulatory Mechanisms aims to identify novel treatment targets by applying high-resolution approaches to complex cardiac disorders.
引用
收藏
页码：343 / 344
页数：2
相关论文
共 50 条
  • [41] Mitochondrial dysfunctions associated with chronic respiratory diseases and their targeted therapies: an update
    Chellappan, Dinesh Kumar
    Dharwal, Vivek
    Paudel, Keshav Raj
    Jha, Niraj Kumar
    MacLoughlin, Ronan
    Oliver, Brian G.
    M Hansbro, Philip
    Dua, Kamal
    FUTURE MEDICINAL CHEMISTRY, 2021, 13 (15) : 1249 - 1251
  • [42] Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies
    Xiumei Wu
    Mengyun Xu
    Mengya Geng
    Shuo Chen
    Peter J. Little
    Suowen Xu
    Jianping Weng
    Signal Transduction and Targeted Therapy, 8
  • [43] Targeting ion homeostasis in metabolic diseases: Molecular mechanisms and targeted therapies
    Zhang, Yanjiao
    Ma, Kaile
    Fang, Xinyi
    Zhang, Yuxin
    Miao, Runyu
    Guan, Huifang
    Tian, Jiaxing
    PHARMACOLOGICAL RESEARCH, 2025, 212
  • [44] In Vivo Tracking of Cell Therapies for Cardiac Diseases with Nuclear Medicine
    Moreira, Mayra Lorena
    Medeiros, Priscylla da Costa
    Lopes de Souza, Sergio Augusto
    Gutfilen, Bianca
    Rosado-de-Castro, Paulo Henrique
    STEM CELLS INTERNATIONAL, 2016, 2016
  • [45] Cardiac Complications of HER2-Targeted Therapies in Breast Cancer
    Addetia K.
    DeCara J.M.
    Current Treatment Options in Cardiovascular Medicine, 2016, 18 (6)
  • [46] Pharmacovigilance Analysis of Cardiac Toxicities Associated With Targeted Therapies for Metastatic NSCLC
    Waliany, Sarah
    Zhu, Han
    Wakelee, Heather
    Padda, Sukhmani K.
    Das, Millie
    Ramchandran, Kavitha
    Myall, Nathaniel J.
    Chen, Thomas
    Witteles, Ronald M.
    Neal, Joel W.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (12) : 2029 - 2039
  • [47] Cardiac Toxicity of Targeted Therapies Used in the Treatment for Solid Tumours: A Review
    Svoboda, Marek
    Poprach, Alexandr
    Dobes, Svatopluk
    Kiss, Igor
    Vyzula, Rostislav
    CARDIOVASCULAR TOXICOLOGY, 2012, 12 (03) : 191 - 207
  • [48] Cardiac Toxicity of Targeted Therapies Used in the Treatment for Solid Tumours: A Review
    Marek Svoboda
    Alexandr Poprach
    Svatopluk Dobes
    Igor Kiss
    Rostislav Vyzula
    Cardiovascular Toxicology, 2012, 12 : 191 - 207
  • [49] Targeted therapies
    Loriot, Y.
    ONCOLOGIE, 2013, 15 (7-8) : 387 - 389
  • [50] Targeted Therapies
    Talevi, Alan
    Castro, Guillermo R.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2017, 17 (03) : 186 - 187
12345